Keywords: b-ms, suspends, lobucavir, studies, bristol-myers, squibb, decided

B-MS suspends lobucavir studies

Article | 25 February 1999

Print This

Bristol-Myers Squibb has decided to suspend its Phase III trials oflobucavir, an antiviral nucleoside analog being tested against hepatitis B ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in